Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it...


Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it had entered into an At Market Issuance Sales Agreement with MLV & Co. to sell up to $75M in stock. The biotech firm also said it issued options to purchase 200K shares each to CEO Steven King and CFO Paul Lytle under the company's stock incentive plan.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs